Zydus receives EIR from USFDA for Dabhasa API manufacturing facility
Zydus Lifesciences has received the Establishment Inspection Report from the United States Food and Drug Administration for its Active Pharmaceutical Ingredient manufacturing facility located at Dabhasa, near Vadodara, Gujarat.










